Cytochrome P450 species involved in the metabolism of quinoline

Carcinogenesis

Volumn 17, Issue 9, 1996, Pages 1989-1996

  Reigh, Geraldine ^a   McMahon, Hugh ^c   Ishizaki, Masao ^c   Ohara, Toshinari ^c   Shimane, Kiyomi ^c   Esumi, Yoshi ^c   Green, Carol ^b   Tyson, Charles ^b   Ninomiya, Shin Ichi ^c  

^a DAIICHI PURE CHEMICALS CO LTD   (Japan)

^b SRI INTERNATIONAL   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450; EPOXIDE; EPOXIDE HYDROLASE; MUTAGENIC AGENT; QUINOLINE; QUINOLINE DERIVATIVE; UNSPECIFIC MONOOXYGENASE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG METABOLISM; ENZYME ACTIVITY; HUMAN; HUMAN CELL; KINETICS; LIVER CARCINOGENESIS; LIVER MICROSOME; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0029791270     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/17.9.1989     Document Type: Article

References (18)

1. Nagao, M., Yahagi, T., Seino, Y. Sugimura, T. and Ito, N. (1977) Mutagenicities of quinoline and its derivatives. Mutat. Res., 42, 335-342.
2. Tada, M., Takahashi, K., Kawazoe, Y. and Ito, N. (1980) Binding of quinoline to nucleic acid in a subcellular microsomal system. Chem.-Biol. Interactions, 29, 257-266.
3. Hollstein, M., Talcott, R. and Wei, E. (1978) Quinoline: conversion to a mutagen by human and rodent liver. J. Natl. Cancer Inst., 60, 405-410.
4. Guengerich, F.P. (1988) Roles of cytochrome P-450 enzymes in chemical carcinogenesis and cancer chemotherapy. Cancer Res., 48, 2946-2954.
5. Saeki, K., Takahashi, K. and Kawazoe, Y. (1993) Metabolism of mutagenicity-deprived 3-fluoroquinoline: comparison with mutagenic quinoline. Biol. Pharm. Bull., 16, 232-234.
6. Omura, T. and Sato, R. (1964) The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature. J. Biol. Chem., 239, 2370-2378.
7. Lowry, O.H., Rosebrough, N.J., Farr, A.L. and Randall, R.J. (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem., 193, 265-275.
8. Agarwal, S.K., Boyd, D.R., Porter, H.P., Jennings, W.B., Crossman, S.J. and Jerina, D.M. (1986) Arene oxides and trans-dihydrodiols of quinoline. Tetrahedron Lett., 27, 4253-4256.
9. Sesardic, D., Boobis, A.R., Murray, B.P., Murray, S., Segura, J., De La Torre, R. and Davies, D.S. (1990) Furafylline is a potent and selective inhibitor of cytochrome P4501A2 in man. Br. J. Clin. Pharmacol., 29, 651-663.
10. Ono, S., Hatanaka, T., Hotta, H., Tsutsui, M., Satoh, T. and Gonzalez, F.J. (1995) Chlorzoxazone is metabolized by human CYP1A2 as well as by human CYP2E1. Pharmacogenetics, 5, 143-150.
11. Lu, A. Y.H. and Miwa, G.T. (1980) Molecular properties and biological functions of microsomal epoxide hydrase. Annu. Rev. Pharmacol. Toxicol., 20, 513-531.
12. Levin, W., Thomas, P.E., Korzeniowski, D., Seifried, H., Jerina, D.M. and Lu, A.W.H. (1978) Liver microsomal epoxide hydratase: activation, inhibition, and immunological properties of the purified enzyme. Mol. Pharmacol., 14, 1107-1120.
13. Raunio, H., Syngelma, T., Pasanen, M., Juvonen, R., Honkakoski, P., Kairaluoma, M.A., Sotaniemi, E., Lang, M.A. and Pelkonen, O. (1988) Immunochemical and catalytic studies on hepatic coumarin 7-hydroxylase in man, rat, and mouse. Biochem. Pharmacol., 37, 3889-3895.
14. Tada, M., Takahashi, K. and Kawazoe, Y. (1982) Metabolites of quinoline, a heptacarcinogen, in a subcellular microsomal system. Chem. Pharm. Bull., 30, 3834-3837.
15. Guengerich, F.P., Dannan, G.A., Wright, S.T., Martin, M.V. and Kaminsky, L.S. (1982) Purification and characterization of liver microsomal cytochromes P-450: electrophoretic, spectral, catalytic, and immunochemical properties and inducibility of eight isozymes isolated from rats treated with phenobarbital or β-naphtoflavone. Biochemistry, 21, 6019-6030.
16. Guengerich, F.P. and McDonald, T.L. (1984) Chemical mechanisms of catalysis by cytochromes P-450: a unified view. Acc. Chem. Res., 17, 9-16.
17. Takahashi, K., Kamiya, M., Sengoku, Y., Kohda, K. and Kawazoe, Y. (1988) Deprivation of the mutagenic property of quinoline: inhibition of mutagenic metabolism by fluorine substitution. Chem. Pharm. Bull., 36, 4630-4633.
18. Guengerich, F.P., Kim, D.-H. and Iwasaki, M. (1991) Role of human cytochrome P-450 IIE1 in the oxidation of many low molecular weight cancer suspects. Chem. Res. Toxicol., 4, 168-179.